Detalhe da pesquisa
1.
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy.
Sex Transm Infect
; 95(8): 619-625, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076456
2.
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.
Virus Genes
; 55(3): 290-297, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796743
3.
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
BMC Infect Dis
; 19(1): 246, 2019 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871487
4.
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.
J Clin Microbiol
; 55(9): 2827-2837, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701420
5.
Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia.
J Clin Microbiol
; 53(9): 2935-41, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135872
6.
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.
Clin Infect Dis
; 58(8): 1156-64, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429430
7.
Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs.
BMC Med Genet
; 15: 76, 2014 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986243
8.
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.
J Antimicrob Chemother
; 68(10): 2205-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687186
9.
Down Syndrome: how to communicate the diagnosis.
Ital J Pediatr
; 49(1): 18, 2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759877
10.
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
New Microbiol
; 35(1): 17-25, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378549
11.
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.
Front Med (Lausanne)
; 9: 1006891, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530924
12.
Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection.
Pharmaceuticals (Basel)
; 15(4)2022 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455400
13.
A reassessment of Jackson's checklist and identification of two Down syndrome sub-phenotypes.
Sci Rep
; 12(1): 3104, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210468
14.
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.
J Antimicrob Chemother
; 66(11): 2615-23, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21890537
15.
Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013-2020.
Viruses
; 13(2)2021 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33503987
16.
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings.
J Clin Virol
; 130: 104534, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32769022
17.
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes.
J Hepatol
; 50(3): 461-70, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19041149
18.
Historical resistance profile helps to predict salvage failure.
Antivir Ther
; 14(2): 285-91, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19430103
19.
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
BMC Infect Dis
; 9: 111, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19607681
20.
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen.
Antivir Ther
; 24(5): 321-331, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977466